Trade Arcadia Biosciences, Inc. - RKDA CFD

Trading Conditions

• Spread: 0.07
• Long position overnight feeLong position overnight feeMargin. Your investmentUS$1,000.00Overnight feeCharges from full value of position-0.026179 %(-US$1.05)Trade size with leverage ~ US$5,000.00Short position overnight fee ~ US$4,000.00Go to platform: -0.026179%
• Short position overnight feeShort position overnight feeMargin. Your investmentUS$1,000.00Overnight feeCharges from full value of position0.003957 %(US$0.16)Trade size with leverage ~ US$5,000.00Short position overnight fee ~ US$4,000.00Go to platform: 0.003957%
• Overnight fee time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 20
• Stock exchange: United States of America
• Commission on trade: 0%

• Margin. Your investment: US$1,000.00
• Overnight feeCharges from full value of position: -0.026179 %
  (-US$1.05)

• Margin. Your investment: US$1,000.00
• Overnight feeCharges from full value of position: 0.003957 %
  (US$0.16)

Key Stats

• Prev. Close: 1.9
• Open: 1.9
• 1-Year Change: -69.26%
• Day's Range: 1.9 - 2.01

Arcadia Biosciences, Inc. Company profile

About Arcadia Biosciences Inc

Arcadia Biosciences, Inc is engaged in developing crop improvements. The Company develops crops in wheat, soy and hemp, designed for farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products for industrial applications. It uses breeding techniques to develop. The Company's GoodWheat product ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. Its GoodHemp seed catalog delivers hemp seeds, transplants and extracts. It offers Sonova GLA Safflower Oil by growing safflower plants producing seed which are high in gamma-linolenic acid (GLA). It also offers its Sonova GLA as a nutritional additive to adult dry dog and cat food formulations.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Arcadia Biosciences Inc revenues increased from $904K to $4.6M. Net loss decreased 60% to $5.4M. Revenues reflect SubTotal increase from $630K to $4.5M, Royalty increase of 48% to $86K. Lower net loss reflects Other income, net increase from $82K to $10.2M (income), Research and development - Balancing decrease of 63% to $2.1M (expense), Valuation of Inventory - Gain/Loss decrease of 39% to $1.8M (expense).